UNIC
SFDR Classification

Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc

ISR Label
Latest NAV
15.0603 EUR
Performance YTD

-

Assets Under Management
296m EUR
TER
0.15%
ISIN
LU2023678282
Dividend Policy
Capitalisation
Investment Objective

The Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc is a UCITS compliant exchange traded fund that aims to track the MSCI ACWI IMI Disruptive technology ESG Filtered Index. The index aims to represent the performance of companies expected to derive significant revenue from areas like 3D printing, the ‘Internet of Things’, cloud computing, Fintech, digital payments, healthcare, robotics, clean energy and smart grids, and cybersecurity. The index methodology employs a set of key words of theme-related products, services and concepts built using natural language processing and data analysis techniques. These key words help identify relevant companies based on the proportion of revenue that can be linked to the Disruptive Technology theme. Annually, the expression of the high-level index objective and associated sub-themes are reviewed with the consultative input of a thematic industry expert retained by MSCI. The index is filtered based on MSCI ESG Ratings, controversy scores and certain business activities, with final stock weights based on a combined score of three fundamental metrics: 1-year sales growth, Return on Invested Capital, and % sales spent on R&D and Capex. Lyxor ETFs are efficient investment vehicles listed on exchange that offer transparent, liquid and low-cost exposure to the underlying benchmark index.

As announced in March 2020, effective October 1st, 2021, the TER was reset to its target level of 0.45%.

UNIC
SFDR Classification

Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc

ISR Label

PERFORMANCE

Performance history

Legend:

The figures relating to [past performances / simulated past performances / past performances and simulated past performances] refer or relate to past periods and are not a reliable indicator of future results. This also applies to historical market data.

Product
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index
Data as of 23/09/2021, Source: Lyxor International Asset Management
Product 3Y 5Y 10Y ALL
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF - - - 80.16%
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index - - - 81.34%
Data as of 23/09/2021, Source: Lyxor International Asset Management
Product 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF - - - - - - - - - -
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index - - - - - - - - - -
Data as of 23/09/2021, Source: Lyxor International Asset Management
Product
From 23/09/2019
To 23/09/2020
From 23/09/2018
To 23/09/2019
From 23/09/2017
To 23/09/2018
From 23/09/2016
To 23/09/2017
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc ETF - - - -
MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index Benchmark Index - - - -
Data as of 23/09/2021, Source: Lyxor International Asset Management

NAV History

Date NAV Currency Fund AUM
23/09/2021 15.0603 EUR 296m EUR
22/09/2021 14.8382 EUR 292m EUR
21/09/2021 14.7484 EUR 290m EUR
20/09/2021 14.7027 EUR 289m EUR
17/09/2021 15.0197 EUR 295m EUR

Dividend History

This fund does not distribute any dividend.

HOLDINGS

This ETF uses physical replication to track the performance of the index. As such, the holdings of the ETF reflect those of the benchmark index.

Name Currency Weight Sector Country
PROTHENA CORP PLC USD 2.34% Health Care Ireland
DATADOG INC - CLASS A USD 1.85% Information Technology United States
CLOUDFLARE INC - CLASS A USD 1.52% Information Technology United States
EDITAS MEDICINE INC USD 1.38% Health Care United States
Arcturus Therapeutics Ltd USD 1.35% Health Care United States
MIRATI THERAPEUTICS INC USD 1.32% Health Care United States
ROCK TENN COMPANY -CL A USD 1.29% Financials United States
NOVAVAX INC USD 1.29% Health Care United States
OBI PHARMA INC TWD 1.21% Health Care Taiwan
ANAPTYSBIO INC USD 1.21% Health Care United States
Name Listing Currency Quantity Weight Sector Country
PROTHENA CORP PLC USD 105,142 2.34% Health Care Ireland
DATADOG INC - CLASS A USD 42,690 1.85% Information Technology United States
CLOUDFLARE INC - CLASS A USD 37,935 1.52% Information Technology United States
EDITAS MEDICINE INC USD 80,092 1.38% Health Care United States
Arcturus Therapeutics Ltd USD 87,742 1.35% Health Care United States
MIRATI THERAPEUTICS INC USD 27,135 1.32% Health Care United States
ROCK TENN COMPANY -CL A USD 264,477 1.29% Financials United States
NOVAVAX INC USD 18,983 1.29% Health Care United States
OBI PHARMA INC TWD 1.11m 1.21% Health Care Taiwan
ANAPTYSBIO INC USD 147,528 1.21% Health Care United States

This funds does not use sec/lending

Index Information

Full Name MSCI ACWI IMI Disruptive Technology ESG Filtered Net Total Return Index
Index Type Performance
Index Bloomberg Ticker MXACDSRT
Index Currency USD
Number of Index Components 186
Further Information www.msci.com
Dividend Yield (%) 0.5
Data as of 22/09/2021

Index Composition Breakdown

Currency Breakdown

USD 73.85%
EUR 8.28%
TWD 3.58%
CHF 3.01%
Others 2.91%
CAD 2.36%
HKD 1.69%
JPY 1.6%
CNH 1.57%
SEK 1.17%

Sector Breakdown

Information Technology 44.18%
Health Care 40%
Industrials 6.65%
Utilities 3.28%
Communication Services 2.1%
Financials 1.83%
Energy 1.07%
Consumer Discretionary 0.51%
Materials 0.38%

Countries Breakdown

United States 71.16%
China 3.96%
Germany 3.68%
Taiwan 3.58%
Switzerland 3.01%
Ireland 2.34%
Canada 1.97%
France 1.65%
Japan 1.6%
Sweden 1.17%
Netherlands 1.01%
Australia 0.91%
United Kingdom 0.8%
Belgium 0.65%
Puerto Rico 0.6%
Denmark 0.6%
South Korea 0.49%
Spain 0.4%
Italy 0.23%
Thailand 0.12%
Hong Kong 0.1%
Data as of 22/09/2021, Source: Lyxor International Asset Management

CHARACTERISTICS

Main Fund Characteristics

ISIN LU2023678282
UCITS Yes
Share Class Currency USD
Assets Under Management 296.1m EUR
Total Expense Ratio 0.15%
Dividend Treatment Capitalisation
EU-SD Status Out of Scope
Fund Type SICAV
Domicile Luxembourg
Replication Method Direct (Physical)
Sampling No
Securities Lending No
Umbrella AUM 12,905.2m EUR
Portfolio Managers Raphaël Dieterlen, Salah BENAISSSA
Financial Year End 31/10/2021
Inception Date 02/03/2020
Minimum Investment 1 Share
SFDR Classification 8

DISCLAIMER: This fund includes a risk of capital loss. Investors therefore may not recover all or part of their initial investment. The redemption value of this fund may be less than the amount initially invested. In a worst case scenario, investors could sustain the loss of their entire investment. Be sure to read carefully the Key Investor Information document, and the “risk factors” section of a fund’s performance to better understand the risks involved.

Trading Information

Exchange Ticker Bloomberg Listing Currency Currency Hedged Listing Date Dividend Policy ADV 3M ISIN Fund AUM in CCY
Euronext UNIC FP EUR - 21/04/2020 Capitalisation 73,478EUR LU2023678282 296m EUR
Xetra DRUP GY EUR - 30/04/2020 Capitalisation 282,555EUR LU2023678282 296m EUR
Borsa Italiana UNIC IM EUR - 30/04/2020 Capitalisation 529,309EUR LU2023678282 296m EUR
BMV UNICN MM MXN - 18/05/2021 Capitalisation - LU2023678282 6,968m MXN
LSE UNIC LN USD - 30/04/2020 Capitalisation 35,959USD LU2023678282 348m USD
LSE DTEC LN GBP - 30/04/2020 Capitalisation 53,252GBP LU2023678282 253m GBP
SIX Swiss Ex QBIT SW CHF - 23/04/2020 Capitalisation 45,407CHF LU2023678282 321m CHF
*Related Shareclasses

Passporting Information

UK
Spain
France
Germany
Belgium
Netherlands
Italy
Switzerland
Luxembourg
Austria
Sweden
Finland
Norway
Denmark
Korea
Data as of 23/09/2021, Source: Lyxor International Asset Management

NEWS

Notice to Shareholders
28/01/2021

Notice to Shareholders Annual general meeting of Lyxor Index Fund